Literature DB >> 27539827

Intramyocardially Transplanted Neonatal Cardiomyocytes (NCMs) Show Structural and Electrophysiological Maturation and Integration and Dose-Dependently Stabilize Function of Infarcted Rat Hearts.

Martina Maass, Benjamin Krausgrill, Simon Eschrig, Tobias Kaluschke, Katja Urban, Gabriel Peinkofer, Tobias G Plenge, Simon Oeckenpöhler, Martin Raths, Dennis Ladage, Marcel Halbach, Jürgen Hescheler, Jochen Müller-Ehmsen.   

Abstract

Cardiac cell replacement therapy is a promising therapy to improve cardiac function in heart failure. Persistence, structural and functional maturation, and integration of transplanted cardiomyocytes into recipients' hearts are crucial for a safe and efficient replacement of lost cells. We studied histology, electrophysiology, and quantity of intramyocardially transplanted rat neonatal cardiomyocytes (NCMs) and performed a detailed functional study with repeated invasive (pressure-volume catheter) and noninvasive (echocardiography) analyses of infarcted female rat hearts including pharmacological stress before and 3 weeks after intramyocardial injection of 5 × 106 (low NCM) or 25 × 106 (high NCM) syngeneic male NCMs or medium as placebo (Ctrl). Quantitative real-time polymerase chain reaction (PCR) for Y-chromosome confirmed a fivefold higher persisting male cell number in high NCM versus low NCM after 3 weeks. Sharp electrode measurements within viable slices of recipient hearts demonstrated that transplanted NCMs integrate into host myocardium and mature to an almost adult phenotype, which might be facilitated through gap junctions between host myocardium and transplanted NCMs as indicated by connexin43 in histology. Ejection fraction of recipient hearts was severely impaired after ligation of left anterior descending (LAD; pressure-volume catheter: 39.2 ± 3.6%, echocardiography: 39.9 ± 1.4%). Repeated analyses revealed a significant further decline within 3 weeks in Ctrl and a dose-dependent stabilization in cell-treated groups. Consistently, stabilized cardiac function/morphology in cell-treated groups was seen in stroke volume, cardiac output, ventricle length, and wall thickness. Our findings confirm that cardiac cell replacement is a promising therapy for ischemic heart disease since immature cardiomyocytes persist, integrate, and mature after intramyocardial transplantation, and they dose-dependently stabilize cardiac function after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27539827      PMCID: PMC5657691          DOI: 10.3727/096368916X692870

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  34 in total

Review 1.  Stem cell engraftment and survival in the ischemic heart.

Authors:  Kai Hong Wu; Xu Ming Mo; Zhong Chao Han; Bin Zhou
Journal:  Ann Thorac Surg       Date:  2011-09-28       Impact factor: 4.330

Review 2.  Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease.

Authors:  Y Wen; L Meng; Y Ding; J Ouyang
Journal:  Int J Clin Pract       Date:  2011-08       Impact factor: 2.503

3.  Electrophysiological and morphological maturation of murine fetal cardiomyocytes during electrical stimulation in vitro.

Authors:  Sven Baumgartner; Marcel Halbach; Benjamin Krausgrill; Martina Maass; Sureshkumar Perumal Srinivasan; Raja Ghazanfar Ali Sahito; Gabriel Peinkofer; Filomain Nguemo; Jochen Müller-Ehmsen; Jürgen Hescheler
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-06-09       Impact factor: 2.457

4.  Ventricular slices of adult mouse hearts--a new multicellular in vitro model for electrophysiological studies.

Authors:  Marcel Halbach; Frank Pillekamp; Konrad Brockmeier; Jürgen Hescheler; Jochen Müller-Ehmsen; Michael Reppel
Journal:  Cell Physiol Biochem       Date:  2006-08-14

5.  Establishment and characterization of a mouse embryonic heart slice preparation.

Authors:  Frank Pillekamp; Michael Reppel; Vera Dinkelacker; Yaqi Duan; Nathalie Jazmati; Wilhelm Bloch; Konrad Brockmeier; Juergen Hescheler; Bernd K Fleischmann; Ruediger Koehling
Journal:  Cell Physiol Biochem       Date:  2005

6.  Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function.

Authors:  Jochen Müller-Ehmsen; Kirk L Peterson; Larry Kedes; Peter Whittaker; Joan S Dow; Tiffany I Long; Peter W Laird; Robert A Kloner
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

7.  Cellular cardiomyoplasty improves survival after myocardial injury.

Authors:  Wilhelm Roell; Zhong J Lu; Wilhelm Bloch; Sharon Siedner; Klaus Tiemann; Ying Xia; Eva Stoecker; Michaela Fleischmann; Heribert Bohlen; Robert Stehle; Eugen Kolossov; Gottfried Brem; Klaus Addicks; Gabriele Pfitzer; Armin Welz; Juergen Hescheler; Bernd K Fleischmann
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

8.  Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells.

Authors:  Marcel Halbach; Gabriel Peinkofer; Sven Baumgartner; Martina Maass; Mirjam Wiedey; Klaus Neef; Benjamin Krausgrill; Dennis Ladage; Azra Fatima; Tomo Saric; Jürgen Hescheler; Jochen Müller-Ehmsen
Journal:  Cardiovasc Res       Date:  2013-09-16       Impact factor: 10.787

9.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

10.  Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.

Authors:  Eugen Kolossov; Toktam Bostani; Wilhelm Roell; Martin Breitbach; Frank Pillekamp; Jens M Nygren; Philipp Sasse; Olga Rubenchik; Jochen W U Fries; Daniela Wenzel; Caroline Geisen; Ying Xia; Zhongju Lu; Yaqi Duan; Ralf Kettenhofen; Stefan Jovinge; Wilhelm Bloch; Heribert Bohlen; Armin Welz; Juergen Hescheler; Sten Eirik Jacobsen; Bernd K Fleischmann
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  4 in total

Review 1.  Remuscularization of the failing heart.

Authors:  Wolfram-Hubertus Zimmermann
Journal:  J Physiol       Date:  2017-04-25       Impact factor: 5.182

2.  N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.

Authors:  Xi Lou; Meng Zhao; Chengming Fan; Vladimir G Fast; Mani T Valarmathi; Wuqiang Zhu; Jianyi Zhang
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

3.  Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes.

Authors:  Naresh Kumar; Julie A Dougherty; Heather R Manring; Ibrahim Elmadbouh; Muhamad Mergaye; Andras Czirok; Dona Greta Isai; Andriy E Belevych; Lianbo Yu; Paul M L Janssen; Paolo Fadda; Sandor Gyorke; Maegen A Ackermann; Mark G Angelos; Mahmood Khan
Journal:  Sci Rep       Date:  2019-09-12       Impact factor: 4.379

4.  Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages.

Authors:  Gabriel Peinkofer; Martina Maass; Kurt Pfannkuche; Agapios Sachinidis; Stephan Baldus; Jürgen Hescheler; Tomo Saric; Marcel Halbach
Journal:  Stem Cell Res Ther       Date:  2021-01-08       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.